Obesity News
🇪🇺 EMAEMA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–6 of 6 articles
Boehringer Ingelheim's Survodutide Achieves 16.6% Weight Loss in Phase 2 Obesity Trial, Outperforming Current Market Leaders
Novo Nordisk Presents New Wegovy Data for Women with Obesity at European Congress on Obesity 2026
BioPharma Clinical Trials: Gene Therapy, Obesity, and Oncology Updates
Pharma 2026: Key Takeaways from EU Biopharma & Medtech
Reuters Pharma EU: Funding & Dealmaking Key Takeaways
FDA Approves Idvynso, Ascentage Pharma at ASCO 2026